Clinical Edge Journal Scan

Link between Western diet, intestinal microbiota, and CRC: Findings from 2 U.S. cohort studies


 

Key clinical point: A Western-style diet (rich in red and processed meat) is more strongly associated with colorectal cancer (CRC) incidence for tumors containing higher amounts of polyketide synthase ( pks)+ Escherichia coli.

Major finding: The association between the Western diet score and CRC incidence was stronger for tumors with higher pks+ E. coli levels ( Pheterogeneity = .014). Individuals in the highest vs lowest tertile of diet score with pks+ E. coli -high, -low, and -negative tumors had adjusted hazard ratios of 3.45 (95% CI 1.53-7.78; Ptrend = .001), 1.22 (95% CI 0.57-2.63), and 1.10 (95% CI 0.85-1.42), respectively.

Study details: This study analyzed the dietary information of 134,775 individuals enrolled in 2 U.S.-wide longitudinal prospective cohort studies using semiquantitative food frequency questionnaires.

Disclosures: This study was sponsored by the US National Institutes of Health, among others. Some authors declared previously serving as advisors or consultants for or receiving research grants from various sources.

Source: Arima K et al. Western-style diet, pks island-carrying Escherichia coli , and colorectal cancer: Analyses from two large prospective cohort studies. Gastroenterology. 2022 (Jun 24). Doi: 10.1053/j.gastro.2022.06.054

Recommended Reading

Study confirms BRCA1 and BRCA2 linked to seven cancers
MDedge Hematology and Oncology
Medicare to cover colonoscopy after positive fecal test
MDedge Hematology and Oncology
New insights into worldwide biliary tract cancer incidence, mortality
MDedge Hematology and Oncology
Pregnancy, breastfeeding, and more linked to lower CRC risk
MDedge Hematology and Oncology
Liver cancer risk persists after direct-acting antiviral treatment for HCV
MDedge Hematology and Oncology
U.S. hot, cold spots of young-onset CRC may help target interventions
MDedge Hematology and Oncology
Marital status plays modest role in gastric cancer overall survival
MDedge Hematology and Oncology
Life-threatening adverse events in liver cancer less frequent with ICI therapy
MDedge Hematology and Oncology
Barrett’s esophagus: AGA screening update ‘goes above and beyond’
MDedge Hematology and Oncology
Stage II colon cancer: ctDNA-guided approach reduces adjuvant chemotherapy use without compromising recurrence risk
MDedge Hematology and Oncology